cancer vaccine

Ultimovacs’ vaccine boosts survival in BMS combo

Ultimovacs’ cancer vaccine shows survival benefit in BMS combo trial despite missing primary endpoint

Anika Sharma

Ultimovacs, the Norwegian biotech company, has staged a remarkable comeback for its cancer vaccine candidate. Despite encountering a setback earlier ...

Moderna has partnered with Immatics to develop mRNA-based cancer vaccines, bispecifics and cell therapies. The deal includes a $120 million upfront payment and up to $1.7 billion in milestones.

Moderna expands cancer vaccine portfolio with Immatics deal worth up to $1.7B

Anika Sharma

Moderna is intensifying its focus on cancer vaccines and cell therapies through a newly announced research partnership with Immatics, a ...

Melanoma, Opdivo, Yervoy, survival time, cancer vaccine, Ultimovacs

Ultimovacs Explores Innovative Approaches to Conclude Phase 2 Cancer Trial Amid Prolonged Anticipation for Survival Data

Anika Sharma

Ultimovacs, a Norwegian biotech company, is grappling with prolonged delays in obtaining midphase melanoma trial data, prompting the company to ...